| Status: Medicine does not meet criteria for AWMSG assessment | |
Excluded from appraisal by AWMSG as meets exclusion criteria 1. See AWMSG criteria for appraising a medicine (PDF, 430Kb) for information.
|
|
Medicine details |
|
| Medicine name | clobetasol propionate (Clarelux®) |
| Formulation | 500 micrograms/g cutaneous foam |
| Reference number | 91 |
| Indication | Short course treatment of steroid-responsive dermatoses of the scalp, such as psoriasis, which do not respond to less active steroids |
| Company | 3M Health Care Ltd |
| BNF chapter | Skin |
| Submission type | N/A |
| Status | Medicine does not meet criteria for AWMSG assessment |
| Date of issue | 21/03/2006 |